Wednesday, July 8, 2026

Drug profile · INN

barium sulfate

barium sulfate (E-Z-DISK) is a diagnostic agent. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 17
News articles 0
Congress events 1
Drug details — barium sulfate
US status
approved
Class
Route
ORAL
Patents
0
Programs
17
Data quality
0.84

Quick answer

barium sulfate (E-Z-DISK) is a diagnostic agent. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN barium sulfate
Brand E-Z-DISK
Mechanism Diagnostic agent
Route ORAL
Formulation PASTE

Mechanism of action

Diagnostic agent

Approval history

Authority Status Date
FDA approved

Congress & event coverage

Pipeline programs

  1. LI Phase 3 · Teva Pharma · Squamous Cell Carcinoma of the Oral Cavity
  2. Pembrolizumab (K) Phase 3 · Merck KGaA, Darmstadt · Breast Cancer
  3. Tralesinidase alfa (TA) Phase 3 · SPRUCE BIOSCIENCES · MPS IIIB
  4. one percent ultrasound power in CMICS Phase 3 · Hospital Authority · Cataract
  5. (Z)-endoxifen Phase 2 · ATOSSA THERAPEUTICS · Breast Neoplasms
  6. 217043 Phase 2 · GSK Glaxo Smith · Infections, Meningococcal
  7. ML-004 (IR)/(ER) tablet Phase 2 · MapLight Therapeutics · Autism Spectrum Disorder
  8. P38 Inhibitor (4) 150mg Phase 2 · HOFFMANN-LA ROCHE · Rheumatoid Arthritis

Frequently asked questions

What is barium sulfate?

barium sulfate (E-Z-DISK) is a diagnostic agent. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for barium sulfate?

E-Z-DISK is a marketed brand name for barium sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of barium sulfate?

barium sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.